Story perspectives

AI Tool Predicts Colon Cancer Metastasis with 80% Accuracy

3/22/2026

Center

Researchers Develop MangroveGS

Researchers at the University of Geneva developed Mangrove Gene Signatures (MangroveGS), an AI tool predicting colon cancer metastasis risk and recurrence with nearly 80% accuracy.
MangroveGS analyzes gene expression in colon cancer cells and integrates signals from stomach, lung, and breast cancers to guide personalized treatment options.
The study frames cancer as a distorted developmental process and suggests this perspective could yield therapeutic targets and optimize trial participant selection.

Left

AI Tool Predicts Alzheimer's

A Worcester Polytechnic Institute study reports an AI tool that analyzes MRI scans to predict Alzheimer's disease with 93% accuracy.
The model detects patterns of brain volume loss in the hippocampus, amygdala, and entorhinal cortex.
Researchers analyzed 815 MRI scans from participants aged 69 to 84, noting right hippocampus loss among younger individuals.
The findings suggest the tool could serve as an early biomarker for Alzheimer's.

1 of 2

Researchers Develop MangroveGS

Researchers at the University of Geneva developed Mangrove Gene Signatures (MangroveGS), an AI tool predicting colon cancer metastasis risk and recurrence with nearly 80% accuracy.
MangroveGS analyzes gene expression in colon cancer cells and integrates signals from stomach, lung, and breast cancers to guide personalized treatment options.
The study frames cancer as a distorted developmental process and suggests this perspective could yield therapeutic targets and optimize trial participant selection.

1 / 2